Bicara Therapeutics logo in transparent PNG and vectorized SVG …
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that …
Bicara Therapeutics
At Bicara, we are attacking cancer head-on by combining the precision of targeted therapies with the power of tumor-microenvironment modulators to create better medicines for patients. We …
Attachment - GlobeNewswire
Bicara Logo STRUCK.png. Format PNG. Source Bicara Therapeutics Inc.
About - Bicara Therapeutics
Bicara Therapeutics is a clinical-stage biotechnology company developing first-in-class biologics engineered to combine the precision of well validated, tumor-targeting antibodies with the …
Bicara Therapeutics - LinkedIn
Bicara Therapeutics is a clinical-stage company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of tumor modulators.
Bicara Therapeutics Inc. - MarketWatch
2025年1月24日 · Bicara Therapeutics, Inc. is a clinical-stage biotechnology company and it developing first-in-class biologics engineered to combine the precision of well validated,...
癌症双效疗法生物技术初创公司：Bicara Therapeutics, Inc.(BCAX)
2024年5月1日 · Bicara Therapeutics, Inc. (NASDAQ:BCAX)创立于2020年，总部位于美国马萨诸塞州Boston，全职雇员32人，Bicara Therapeutics 是一家临床阶段的 生物制药公司，开发双 …
Bicara Therapeutics Presents Phase 1/1b Dose Expansion Results …
4 天之前 · BOSTON, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative …
药明生物助力又一家创新药公司美国上市 Bicara Therapeutics (BCAX.US)是一家处于第一阶段的生物技术公司，Bicara ...
2024年8月27日 · Bicara Therapeutics (BCAX.US)是一家处于第一阶段的生物技术公司，Bicara Therapeutics是从印度亿万富翁Kiran Mazumdar-Shaw创立的同胞公司Biocon分拆出来的。 …
Careers - Bicara Therapeutics
At Bicara, we are working towards a shared vision to provide first-in-class, meaningful new therapies to cancer patients. Our work requires us to be visionaries, leaders and achievers. …